Is IVG.AX stock a buy after the pre-market drop?

IVG.AX stock is a speculative HOLD for most investors. Current price A$0.021 trades below averages and lacks near-term catalysts. Consider waiting for drilling results or a capital-strengthening event before buying. Use small position sizes due to volatility and low market cap.

What caused the 27% fall in IVG.AX stock pre-market?

The drop appears driven by heavy selling and low market cap liquidity rather than fresh earnings or disclosures. Volume rose to 387,364, about 1.48x average, which amplified the move on the ASX.

What are Meyka AI's short-term forecasts and price targets for IVG.AX stock?

Meyka AI's model projects a monthly price of A$0.02, implying -4.76% from A$0.021. Targets we reference: downside A$0.01, base A$0.02, optimistic A$0.03. Forecasts are projections, not guarantees.

AU Stocks

IVG.AX down 27% pre-market on ASX: implications and near-term outlook

ByDanny Kontos March 19, 2026March 19, 2026

IVG.AX stock opened the ASX pre-market session under heavy selling, trading at A$0.021 after a -27.59% drop on increased volume. The fall leaves Ingraphite Fpo (IVG.AX) near its year low of A$0.021 and below its 50-day average of A$0.02982. We see this move as a liquidity-driven sell-off rather than an earnings shock, because no earnings release is scheduled. Volume at 387,364 shares is 1.48x average, so short-term traders should expect higher volatility in AUD on the ASX.